본문 바로가기
KERD
논문KCI 등재

Anti-osteoporotic Effects of Unripe Fructus of Rubus coreanus Miquel in Osteoblastic and Osteoclastic Cells

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Osteoporosis is a progressive bone disease characterized by low bone mass which is caused by disturbance in the balance between the activities of osteoblasts and osteoclasts. Postmenopausal osteoporosis is one of the most common disorders in women after menopause, which is linked to an estrogen deficiency and characterized by an excessive loss of trabecular bone. Rubus coreanus has been used for their various pharmacological properties in Asia as a traditional medicine. To investigate the effect of unripe fruits of R. coreanus 30% ethanol extract (RCE) on osteoblast-like cells (MG63) differentiation, we examined the effects of RCE on in vitro osteoblastic differentiation markers, alkaline phosphatase (ALP) activity and receptor activator of nuclear factor κ-B ligand (RANKL) and osteoprotegerin (OPG) expression. The high concentration (50 and 100 μg/mL) of RCE markedly increased ALP activity, whereas decreased the RANKL/OPG. We also investigated the effect of RCE on M-CSF plus RANKL-induced differentiation of pre-osteoclast cells (RAW 264.7). RCE treatment remarkably inhibited M-CSF/RANKL-induced formation of osteoclast-like multinuclear cells from RAW 264.7 cells. Moreover, the inhibitory effect of RCE was reduced by selective estrogen receptor-α antagonist. Our research suggests that suggested that unripe fruits of R. coreanus may act beneficial effects on bone mass by regulating both osteoblast and osteoclast.

Abstract

Osteoporosis is a progressive bone disease characterized by low bone mass which is caused by disturbance in the balance between the activities of osteoblasts and osteoclasts. Postmenopausal osteoporosis is one of the most common disorders in women after menopause, which is linked to an estrogen deficiency and characterized by an excessive loss of trabecular bone. Rubus coreanus has been used for their various pharmacological properties in Asia as a traditional medicine. To investigate the effect of unripe fruits of R. coreanus 30% ethanol extract (RCE) on osteoblast-like cells (MG63) differentiation, we examined the effects of RCE on in vitro osteoblastic differentiation markers, alkaline phosphatase (ALP) activity and receptor activator of nuclear factor κ-B ligand (RANKL) and osteoprotegerin (OPG) expression. The high concentration (50 and 100 μg/mL) of RCE markedly increased ALP activity, whereas decreased the RANKL/OPG. We also investigated the effect of RCE on M-CSF plus RANKL-induced differentiation of pre-osteoclast cells (RAW 264.7). RCE treatment remarkably inhibited M-CSF/RANKL-induced formation of osteoclast-like multinuclear cells from RAW 264.7 cells. Moreover, the inhibitory effect of RCE was reduced by selective estrogen receptor-α antagonist. Our research suggests that suggested that unripe fruits of R. coreanus may act beneficial effects on bone mass by regulating both osteoblast and osteoclast.

참고문헌 (34)

  1. Aubin, J.E., "Principles of Bone Biology", pp.59~81 (2002), Academic Press
  2. Choi, C., "Effect of Rubus coreanus extracts on diabetic osteoporosis by simultaneous regulation of osteoblasts and osteoclasts", Menopause, 19, pp.1043~1051 (2012)
  3. Do, S.H., "Boneprotecting effect of Rubus coreanus by dual regulation of osteoblasts and osteoclasts", Menopause, 15, pp.676~683 (2008)
  4. Fraser, L.A., "Fracture risk associated with continuation versus discontinuation of bisphosphonates after 5 years of therapy in patients with primary osteoporosis: a systematic review and metaanalysis", Ther. Clin. Risk Manag, 7, pp.157~166 (2011)
  5. Geller, S.E., "Toward optimal health: the experts discuss the use of botanicals by women", J. Womens Health (Larchmt), 12, pp.847~852 (2003)
  6. Hamdy, N.A., "Targeting the RANK", RANKL, Curr. Opin. Investig. Drugs, pp.2007, 8[DOI]
  7. Horwood, N.J., "Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells", Endocrinology, 139, pp.4743~4746 (1998)
  8. Hotokezaka, H., "Molecular analysis of RANKL-independent cell fusion of osteoclast-like cells induced by TNF-alpha, lipopolysaccharide, or peptidoglycan", J. Cell. Biochem, 101, pp.122~134 (2007)
  9. Jeong-Hoon Jang, "Physiological Functionalities of Vitis hybrid (Sheridan)-Rubus coreanus Red Wine Made by Saccharomyces cerevisiae", Mycobiology, 39(2), pp.109~112 (2011), 한국균학회
  10. Daeseok Han, "Antifatigue Effect of Rubus coreanus Miquel Extract in Mice", Journal of Medicinal Food, 10(4), pp.689~693 (2007), 한국식품영양과학회
  11. Kansra, S., "Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release", Mol. Cell. Endocrinol, 239, pp.27~36 (2005)
  12. Kansra, S., "Selective estrogen receptor down-regulator and selective estrogen receptor modulators differentially regulate lactotroph proliferation", PLoS One, 5, pp.e10060~ (2010)
  13. Kelly, P.J., "Is osteoporosis a genetically determined disease?", Br. J. Obstet. Gynaecol, 103, pp.20~26 (1996)
  14. Kim, S., "Aqueous extract of unripe Rubus coreanus fruit attenuates atherosclerosis by improving blood lipid profile and inhibiting NF-κB activation via phase II gene expression", J. Ethnopharmacol, 146, pp.515~524 (2013)
  15. Karsenty, G., "The complexities of skeletal biology", Nature, 423, pp.316~318 (2003)
  16. Kearns, A.E., "Receptor activator of nuclear factor kappa B ligand and osteoprotegerin regulation of bone remodeling in health and disease", Endocr. Rev, 29, pp.155~192 (2008)
  17. Khosla, S., "Minireview : the OPG", RANKL, Endocrinology, pp.2001, 142[DOI]
  18. Kostenuik, P.J., "Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption", Curr. Pharm. Des, 7, pp.613~635 (2001)
  19. Koo, H.J., "Effect of the combinatory mixture of Rubus coreanus Miquel and Astragalus membranaceus Bunge extracts on ovariectomy-induced osteoporosis in mice and anti-RANK signaling effect", J. Ethnopharmacol, 151, pp.951~959 (2014)
  20. 구현정, "복분자 미성숙과와 황기 추출물 혼합비율에 의한 조골세포의 활성연구", 한국자원식물학회지, 26(5), pp.658~662 (2013), 한국자원식물학회[DOI]
  21. 구현정, "복분자 유래 성분 protocatechuic acid 투여가 고콜레스테롤 식이로 유도된 생쥐의 지질대사에 미치는 영향", 한국자원식물학회지, 27(4), pp.271~278 (2014), 한국자원식물학회[DOI]
  22. 이정은, "Anti-inflammatory effects of Rubus coreanus Miquel through inhibition of NF-κB and MAP Kinase", Nutrition Research and Practice, 8(5), pp.501~508 (2014), 한국영양학회
  23. Lee, K.H., "Rubus coreanus Miq. extract promotes osteoblast differentiation and inhibits bone-resorbing mediators in MC3T3-E1 cells", Am. J. Chin. Med, 34, pp.643~654 (2006)
  24. Marsden, J., "The menopause, hormone replacement therapy and breast cancer", J. Steroid Biochem. Mol. Biol, 83, pp.123~132 (2002)
  25. McNamara, L.M., "Perspective on post-menopausal osteoporosis: establishing an interdisciplinary understanding of the sequence of events from the molecular level to whole bone fractures", J. R. Soc. Interface, 7, pp.353~372 (2010)
  26. Miksicek, R.J., "Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor", J. Steroid Biochem. Mol. Biol, 49, pp.153~160 (1994)
  27. Oliveira, C.A., "The antiestrogen ICI 182,780 decreases the expression of estrogenreceptor-alpha but has no effect on estrogenreceptor-beta and androgen receptor in rat efferent ductules", Reprod. Biol. Endocrinol, 1, pp.75~ (2003)
  28. Park, J.H., "Induction of heme oxygenase-1 mediates the anti-inflammatory effects of the ethanol extract of Rubus coreanus in murine macrophages", Biochem. Biophys. Res. Commun, 351, pp.146~152 (2006)
  29. Riggs, B.L., "Sex steroids and the construction and conservation of the adult skeleton", Endocr. Rev, 23, pp.279~302 (2002)
  30. Simonet, W.S., "Osteoprotegerin: a novel secreted protein involved in the regulation of bone density", Cell, 89, pp.309~319 (1997)
  31. Thomas, G.P., "Changing RANKL", OPG mRNA expression in differentiating murine primary osteoblasts, 2001, pp.170, 451~460
  32. Udagawa, N., "Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function", Endocrinology, 141, pp.3478~3484 (2000)
  33. Wensel, T.M., "Effects of denosumab on bone mineral density and bone turnover in postmenopausal women", Pharmacotherapy, 31, pp.510~523 (2011)
  34. Yang, H.M., "Antiinflammatory activities of Rubus coreanus depend on the degree of fruit ripening", Phytother. Res, 22, pp.102~107 (2008)

관련 논문AI추천

이 간행물의 다른 논문 (14건)